Document is current
Any future updates will be listed below
-
Authors
Saunders, Lauren M. https://orcid.org/0000-0003-4377-4252
Srivatsan, Sanjay R.
Duran, Madeleine https://orcid.org/0000-0003-1648-2369
Dorrity, Michael W. https://orcid.org/0000-0002-7691-6504
Ewing, Brent
Linbo, Tor H.
Shendure, Jay https://orcid.org/0000-0002-1516-1865
Raible, David W. https://orcid.org/0000-0002-5342-5841
Moens, Cecilia B.
Kimelman, David https://orcid.org/0000-0002-9261-4506
Trapnell, Cole https://orcid.org/0000-0002-8105-4347
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 6 October 2023
First Online: 15 November 2023
Competing interests
: C.T. is a scientific advisory board member, consultant and/or co-founder of Algen Biotechnologies, Altius Therapeutics and Scale Biosciences. J.S. is a scientific advisory board member, consultant and/or co-founder of Cajal Neuroscience, Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Phase Genomics, Adaptive Biotechnologies and Scale Biosciences. The remaining authors declare no competing interests.
